587 related articles for article (PubMed ID: 32755178)
21. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Lung-RADS in Reducing False-Positive Results in a Diverse, Underserved, Urban Lung Cancer Screening Cohort.
Kaminetzky M; Milch HS; Shmukler A; Kessler A; Peng R; Mardakhaev E; Bellin EY; Levsky JM; Haramati LB
J Am Coll Radiol; 2019 Apr; 16(4 Pt A):419-426. PubMed ID: 30146484
[TBL] [Abstract][Full Text] [Related]
23. Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program.
Mortman KD; Devlin J; Giang B; Mortman R; Sparks AD; Napolitano MA
Am J Clin Oncol; 2021 Jun; 44(6):264-268. PubMed ID: 33795600
[TBL] [Abstract][Full Text] [Related]
24. Factors Influencing the False Positive Rate in CT Lung Cancer Screening.
Hammer MM; Byrne SC; Kong CY
Acad Radiol; 2022 Feb; 29 Suppl 2(Suppl 2):S18-S22. PubMed ID: 32893112
[TBL] [Abstract][Full Text] [Related]
25. Adherence to Annual Lung Cancer Screening in a Centralized Academic Program.
Lee G; Hill LP; Schroeder MC; Kraus SJ; El-Abiad KMB; Hoffman RM
Clin Lung Cancer; 2024 Jan; 25(1):e18-e25. PubMed ID: 37925362
[TBL] [Abstract][Full Text] [Related]
26. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
Li J; Chung S; Wei EK; Luft HS
BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
[TBL] [Abstract][Full Text] [Related]
27. Rate of benign nodule resection in a lung cancer screening program.
El Alam R; Byrne SC; Hammer MM
Clin Imaging; 2023 Dec; 104():109984. PubMed ID: 37832324
[TBL] [Abstract][Full Text] [Related]
28. Lung-RADS Version 1.1: Challenges and a Look Ahead, From the
Chelala L; Hossain R; Kazerooni EA; Christensen JD; Dyer DS; White CS
AJR Am J Roentgenol; 2021 Jun; 216(6):1411-1422. PubMed ID: 33470834
[TBL] [Abstract][Full Text] [Related]
29. Patient Identification of Lung Cancer Screening Follow-Up Recommendations and the Association with Adherence.
Triplette M; Wenger DS; Shahrir S; Kross EK; Kava C; Phipps A; Hawes SE; Cole A; Snidarich M; Crothers K
Ann Am Thorac Soc; 2022 May; 19(5):799-806. PubMed ID: 34727513
[No Abstract] [Full Text] [Related]
30. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
31. Management and Outcomes of Suspected Infectious and Inflammatory Lung Abnormalities Identified on Lung Cancer Screening CT.
Mendoza DP; Chintanapakdee W; Zhang EW; Gilman MD; Lennes IT; Frank AJ; Shepard JO; Digumarthy SR
AJR Am J Roentgenol; 2021 Nov; 217(5):1083-1092. PubMed ID: 33377416
[No Abstract] [Full Text] [Related]
32. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
[TBL] [Abstract][Full Text] [Related]
33. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
Byrne SC; Hammer MM
AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352
[No Abstract] [Full Text] [Related]
34. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
Hammer MM; Hunsaker AR
AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
[No Abstract] [Full Text] [Related]
35. Use of Diagnostic CT and Patient Retention in a Lung Cancer Screening Program.
Byrne SC; Hammer MM
J Am Coll Radiol; 2022 Jan; 19(1 Pt A):47-52. PubMed ID: 34752759
[TBL] [Abstract][Full Text] [Related]
36. Promoting lung cancer screening of high-risk patients by primary care providers.
Colamonici M; Khouzam N; Dell C; Auge-Bronersky K; Pacheco E; Rubinstein I; Recht B
Cancer; 2023 Nov; 129(22):3574-3581. PubMed ID: 37449669
[TBL] [Abstract][Full Text] [Related]
37. Beliefs and Intentions to Undergo Lung Cancer Screening among Korean Males.
Bui NC; Lee YY; Suh M; Park B; Cho H; Kim Y; Choi KS
Cancer Res Treat; 2018 Oct; 50(4):1096-1105. PubMed ID: 29141395
[TBL] [Abstract][Full Text] [Related]
38. Timely adherence to follow-up after high-risk lung cancer screenings.
Kee D; Sigel KM; Wisnivesky JP; Kale MS
J Med Screen; 2023 Sep; 30(3):150-155. PubMed ID: 36916158
[TBL] [Abstract][Full Text] [Related]
39. Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling.
Raz DJ; Ismail MH; Haupt EC; Sun V; Park S; Alem AC; Gould MK
Clin Lung Cancer; 2021 Mar; 22(2):83-91. PubMed ID: 33436279
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
